PowerPoint Presentation
Nov 22, 2021 · Less: Net loss attributable to Dutch Bros OpCo prior to the reorganization transactions (74,441) -(68,602) Less: Net loss attributable to non-controlling interests (35,959) - Net income (loss) attributable to Dutch Bros Inc. ($6,738)$6,656 $11,932 Net loss per share of class A and class D common stock: Basic ($0.15) N/A Diluted ($0.15) N/A
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
A New Breed of Battery
s28.q4cdn.comPresentation, and accordingly, neither of them expressed an opinion or provided any other form of assurance with respect thereto for the purpose of this Presentation. ... DCRC and Solid Power believe that these non-GAAP financial measures provide useful information to management and investors regarding certain financial and business trends ...
3Q21 Earnings
s28.q4cdn.comGas Production (MMcfpd) Oil Production (MBopd) 393.8 2,363-251.2 582 81.5 645.0 2,945 81.5 Capital Expenditures1 Drilling & Completion Activity $171 $164 $165 $159 $337 $323 Free Cash Flow2 $125 $263 $387 5 3Q21 Operational & Financial Results 3Q21 Core Performance Highlights • Completed the merger between Cabot and Cimarex • Oil production ...
Analyst and Investor Call to
s28.q4cdn.comDec 17, 2021 · potential efficacy against variants and variant specific vaccine development and anticipated manufacturing, distribution, supply, revenue contribution, growth and performance); Pfizer’s investigational oral antiviral candidate PAXLOVID (including qualitative assessments of available data, including interim data,
Patient Manual - s28.q4cdn.com
s28.q4cdn.comThe Senza®, Senza II™ and Senza Omnia™ neuromodulation systems, when programmed to include a frequency of 10 kHz, are indicated as aids in the management of chronic intractable pain of the lower limbs, including unilateral or bilateral pain, associated with diabetic neuropathy.
PFIZER REPORTS THIRD-QUARTER 2021 RESULTS
s28.q4cdn.commanufacturer of EpiPen and other auto-injector products, which had been reported within the results of the Upjohn Business(6) in the first three quarters of 2020, is included within the Hospital therapeutic area for all periods presented. Business development activities completed in 2020 and 2021 impacted financial results in the periods ...
First, Financial, Quarter, Three, Results, Financial results, First three quarters
REFINITIV STREETEVENTS EDITED TRANSCRIPT
s28.q4cdn.comJan 10, 2022 · So fact needs, say, to make us alert so that we will be always ahead of the virus. And -- but clearly, the situation is way, way better than what we had when we started, when we didn't even have treatments. Christopher Thomas Schott - JPMorgan Chase & Co, Research Division - Senior Analyst Yes, absolutely.
UNITED STATES
s28.q4cdn.comAnnual Report on Form 10-K for the fiscal year ended December 31, 2020 ACIP Advisory Committee on Immunization Practices ALK anaplastic lymphoma kinase Alliance revenues Revenues from alliance agreements under which we co-promote products discovered or developed by other companies or us Allogene Allogene Therapeutics, Inc. Array Array …
To our shareholders, customers,
s28.q4cdn.commission of unleashing the potential of every team. As is the Atlassian way, we set out an ambitious plan, and we executed on it. We played offense throughout this difficult year. We finished fiscal 2021 proud of our resilience and what we accomplished together as a team. Those accomplishments include surpassing
Third Quarter 2021 Earnings Teleconference
s28.q4cdn.comproduct candidates, including anticipated regulatory submissions, data readouts, study starts, approvals, clinical trial result- s and other developing data, ... Cumulative market share is 58.8% in the U.S. and 73.4% in the EU. ... Biosimilars (1) See Slides 38 and 39 for definition of Comirnaty, which is the name for the Pfizer -BioNTech COVID ...
Q2 FY22 | January 27, 2022
s28.q4cdn.comthe trends in our three addressable markets, investing heavily in R&D, playing the long game with our uniquely efficient GTM model, and staying true to our values, Atlassian is delivering a metric tonne of value. Coming off a solid start to the fiscal year, the Atlassian flywheel kept our momentum high and delivered a bonza Q2.
Related documents
Implementation of IND AS – Impact on Corporate Tax
www.wirc-icai.org1 April 2016 with comparatives for March 2016 Once Ind AS is followed, it should be followed for all subsequent years ... basis of Dutch GAAP, tax return is based on these financials and taking into account business principles • Tax rules are largely based on GAAP. As the number of differences between IFRS and GAAP increase, the number of ...
2016, Gaap, Dutch, Dutch gaap
Alles over: actuele waarde als grondslag van waardering - PwC
www.pwc.nlDutch GAAP-onderwerp centraal dat geheel wordt uitgediept. Zo heeft u alles overzichtelijk bij elkaar wat u over dat onderwerp moet weten. Bij PwC willen we een bijdrage leveren aan het vertrouwen in de maatschappij en het oplossen van belangrijke problemen. Wij zijn een netwerk van firma’s in 157 landen met meer dan 223.000 mensen.